Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 0 | 126,473 |
| Gross Profit | N/A | N/A | N/A | N/A | 126,473 |
| Operating Expenses | 28,871 | 34,438 | 3,516 | 44,586 | 76,949 |
| Operating Income | -28,871 | -34,438 | -129,467 | -44,586 | 49,524 |
| Interest Expense | 0 | 618 | -2,667 | 0 | 3,187 |
| Other Income | 2,675 | 2,153 | 2,307 | 3,571 | 215 |
| Pre-tax Income | -26,196 | -32,903 | -124,493 | -41,015 | 46,552 |
| Net Income Continuous | -26,196 | -32,903 | -124,493 | -41,015 | 46,552 |
| Net Income Discontinuous | -6,674 | -7,230 | 83,245 | -6,839 | N/A |
| Net Income | $-32,870 | $-40,133 | $-41,248 | $-47,854 | $46,552 |
| EPS Basic Total Ops | -4.34 | -5.49 | -6.20 | -7.40 | 7.20 |
| EPS Basic Continuous Ops | -3.46 | -4.50 | -19.38 | -6.40 | 7.29 |
| EPS Basic Discontinuous Ops | -0.88 | -0.99 | 13.00 | -1.00 | N/A |
| EPS Diluted Total Ops | -4.34 | -5.49 | -6.20 | -7.40 | 7.20 |
| EPS Diluted Continuous Ops | -3.46 | -4.50 | -19.26 | -6.40 | 7.17 |
| EPS Diluted Discontinuous Ops | -0.88 | -0.99 | 13.00 | -1.00 | N/A |
| EPS Diluted Before Non-Recurring Items | -4.40 | -5.40 | -6.40 | N/A | N/A |
| EBITDA(a) | $-26,966 | $-32,414 | $-1,475 | $-42,509 | $51,152 |